Technology

Wearable technology options can meet patient’s goals.

The upgraded Myopia Software Package offers comprehensive screening, ortho-k fitting, and myopia management in one device.

MonacoPro, the next evolution of Monaco from Optos, retains the powerful ultra-widefield SLO and spectral domain imaging while adding additional key product features.

According to a news release from the company, the VR platform “disrupt[s] traditional diagnostic methods by offering an untethered, all-in-one diagnostic solution that includes a variety of tests such as visual field, progression analysis, color sensitivity, and now visual acuity testing.”

Toronto-based Cellview currently designs and manufactures highly performant diagnostic imaging instruments that leverage internal R&D expertise, according to a news release.

The device was created in collaboration with SlitLED and featuring AutoAquire, RemotePilot, and Multi-Slit views.

Now, the VTO platform features 3 different offerings, 2 which are new and 1 which has been updated, according to the company.

The goal of the agreement is to advance Eleva’s current programs into mid- and late-stage clinical development.

C.Rex is the only MGIS technology on the market that allows for fully titratable 180-360 comprehensive intervention.

Results from the study assisted Notal Vision in receiving De Novo authorization from the US FDA for the SCANLY Home OCT in 2024.

The 2025 Myopia Research Grant will comprise of 3 awards of $500,000 each.

The business move aligns with EssilorLuxottica's strategy to tap into the hearing solutions space, according to the company.

Predictive software will use retinal imaging to identify patient risk for Alzheimer disease and other neurodegenerative diseases.

The webinar will overview new offerings, details about the show’s updated brand and new exhibit hall layout, special events, and announcements regarding this year’s keynote speaker and other main stage sessions.

Let’s look back on some of the top stories on Modern Retina from 2024 as we gear up for an incredible 2025.

A look at the biggest news and advancements in ophthalmology in 2024.

How to be optimistic, responsible, and open in the face of new technology.

The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.

AOA members can receive a $1500 Visa gift card after signing up with Barti and being live on the platform for 3 months.

Vittorio Mena, OD, MS, discusses the impact of a lecture given at Vision Expo West on AI.

Navigation and orientation technologies offer practical solution for people with vision loss.

A new classification system helps patients reach informed decisions.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Navigation and orientation technologies offer practical solution for people with vision loss.

As much as 96% of customers and 60% of patients can get their results in less than a minute with Retinalyze, according to the company.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

NextGen Healthcare's NextGen Ambient Assist is able to recognize medical acronyms and provides automation for both uploading information into the EHR and deleting audio and transcripts to ensure patient privacy is protected.

The Finnish company's new device sports a universal adapter and rebound tonometry technology.

Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.